Lg Chem
Clinical trials sponsored by Lg Chem, explained in plain language.
-
New triple therapy shows promise for diabetes control
Disease control CompletedThis study looked at how well a triple combination of diabetes drugs (zemidapa and metformin) works and how safe it is for people with type 2 diabetes. Over 2,000 adults who were already on certain diabetes medicines took part. The main goal was to see if their blood sugar levels…
Sponsor: LG Chem • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New gout pill shows promise in major trial
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid levels. The goal was to see if taking the drug for 6 months could safely lower uric acid below a target level. Participants received either one of three doses of tigulixostat or a plac…
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if the drug could safely lower uric acid levels over 12 weeks. Participants received one of three doses of the new drug, a placebo, or an active comparator. The main m…
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo pill for diabetes passes early safety check
Knowledge-focused CompletedThis study looked at whether a single pill containing three diabetes medicines (gemigliptin, dapagliflozin, and metformin) works the same as taking them separately. Fifty healthy adults took either the combo pill or the separate pills after a meal, and researchers measured drug l…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated May 26, 2026 10:31 UTC